ADRB1 and melanoma: In addition, sympathetic activity associated with stress has been shown to induce T cell exhaustion via the β1-adrenergic receptor (ADRB1), and deletion of ADRB1 enhances immunotherapy efficacy in both melanoma and pancreatic cancer (9).